Proliferating Fraction During Neoadjuvant Chemotherapy of Primary Breast Cancer in Relation to Objective Local Response and Relapse-free Survival

REFERENCES

• Bonnadonna G, Valagussa P, Zukali R, Salvadori B. Primary chemotherapy in surgically resectable breast cancer. CA A Cancer J Clin 1995; 45: 227–43.
   Google Scholar
• Remvikos Y, Beuzeboc P, Zajdela A. Voillemont N, Magdelé-nat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with response to cytotoxic chemotherapy. J Natl Cancer Inst 1989; 81: 1383–6.
   Google Scholar
• Chevillard S, Pouillart P, Beldjord C, et al. Sequentional assessment of multidrug resistance phenotype and measure-ment of S-phase as predictive markers of breast cancer re-sponse to neoadjuvant chemotherapy. Cancer 1996; 77: 292–300.
   Google Scholar
• Bonetti A, Zaninelli M, Rodella S, et al. Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma. Breast Cancer Res Treatment 1996; 38: 289–97.
   Google Scholar
• Fisher B, Gunduz N, Constantino J, Fisher E, Redmond C. DNA flow cytometric analysis of primary operable breast cancer. Cancer 1991; 68: 1465–75.
   Google Scholar
• Clayton F. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Cancer 1991; 68: 1309–17.
   PubMed Web of Science ®Google Scholar
• Merkel D, Winchester D, Goldschmidt R, August C, Wruck D, Rademaker A. DNA flow cytometry and pathologic grad-ing as prognostic guides in axillary lymph node-negative breast cancer. Cancer 1993; 72: 1926–31.
   PubMed Web of Science ®Google Scholar
• Tahan S, Neuberg D, Dieffenbach A, Yacoub L. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 1993; 71: 3552–9.
   PubMed Web of Science ®Google Scholar
• Bianchi S, Paglierani M, Zampi G, et al. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Cancer 1993; 72: 120–5.
   Google Scholar
• Pisanski T, Ingle J, Schaid D, et al. Patterns of tumor relapse following mastectomy and adjuvant systemic therapy in pa-tients with axillary lymph node-positive breast cancer. Cancer 1993; 72: 1247–60.
   Google Scholar
• Skoog L, Humla S, Isaksson S, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas. Digan Cyto-pathol 1990; 6: 95–8.
   PubMed Web of Science ®Google Scholar
• Soderqvist G, Isaksson E, von Schoultz B, Carlström K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1996; 176: 123–8.
   Google Scholar
• Zaijzek J. Aspiration biopsy cytology. Part 1. In: Wied GL, ed. Cytology of supradiaphragmatic organs in monographs in clinical cytology. 4th vol. Basel: S Karger, 1974.
   Google Scholar
• Gerdes J, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13–20.
   PubMed Web of Science ®Google Scholar
• Skoog I, Wilking N, Humla S, Stenqvist B, Rutqvist L-E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine needle aspirates from primary breast carcinomas during tamoxifen treatment. Diagn Oncol 1991; 1: 282–7.
   Google Scholar
• Gardin G, Alama A, Rosso R, et al. Relationship of varia-tions in cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Res Treatment 1994; 32: 311–8.
   Google Scholar
• Daidone MG, Silvestrini R, Valentinis B, Ferrari L, Bartoli C. Changes in cell kinetics induced by primary chemotherapy in breast cancer. Int J Cancer 1991; 47: 380–3.
   Google Scholar
• Fisher E, Brown A, Mamounas E, et al. Effect of preopera-tive therapy for primary breast cancer (BC) on loco-regional disease, disease-free survival (DFS) and survival (S): results from NSABP-18. Proceedings of ASCO 1997; 18: 172a.
   Google Scholar
• Lee A, Wiley B, Dugan J, et al. Quantitative DNA analysis and proliferation in breast carcinomas. Path Res Pract 1992; 188: 428–32.
   PubMed Web of Science ®Google Scholar